NASDAQ: BIAF - bioAffinity Technologies, Inc.

Yield per half year: -83.83%
Dividend yield: 0.00%
Sector: Healthcare

Share chart bioAffinity Technologies, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About bioAffinity Technologies, Inc.

bioAffinity Technologies, Inc., биотехнологическая компания, занимается разработкой неинвазивных диагностических тестов и целенаправленной терапии рака. Компания предлагает легкие CyPath, диагностический тест для раннего выявления рака легких. Он также исследует таргетные методы лечения рака на клеточном уровне. Компания была основана в 2014 году и базируется в Сан-Антонио, штат Техас.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2022-09-01
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.bioaffinitytech.com
Цена ао 0.215
Change price per day: 0% (0.215)
Change price per week: +1.03% (0.2128)
Change price per month: -57% (0.5)
Change price per 3 month: -72.78% (0.79)
Change price per half year: -83.83% (1.33)
Change price per year: -88.56% (1.88)
Change price per year to date: -75.84% (0.8898)
All parameters

Underestimation

Title Value Grade
P/S 1.2 9
P/BV 4.33 4
P/E 0 0
EV/EBITDA -1.4 0
Total: 5.38

Efficiency

Title Value Grade
ROA, % -122.7 0
ROE, % -242.44 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.1802 10
Total: 9.4

Growth impulse

Title Value Grade
Yield Revenue, % 194820.3 10
Yield Ebitda, % 20.73 4
Yield EPS, % -72.58 0
Total: 5.6
More

Institutions Volume Share, %
CapTrust Financial Advisors 39885 0.35
Geode Capital Management, LLC 36769 0.32
Two Sigma Investments, LP 21642 0.19
Vanguard Group Inc 20000 0.17
State Street Corporation 17600 0.15
Creative Planning 12095 0.11
Ifp Advisors, Inc 5000 0.04
Tower Research Capital LLC (TRC) 2961 0.03
Wells Fargo & Company 41 0
Qube Research & Technologies Ltd 38 0



Head Job title Payment Year of birth
Ms. Maria Zannes J.D. Founder, President, CEO & Director 260.81k 1956 (69 years)
Dr. Vivienne I. Rebel M.D., Ph.D. Executive VP and Chief Medical & Science Officer 238.39k 1966 (59 years)
Mr. Xavier T. Reveles M.S. Chief Operating Officer N/A 1970 (55 years)
Mr. Timothy P. Zannes J.D. Executive VP, Secretary & General Counsel N/A 1953 (72 years)
Dr. William Bauta Ph.D. Senior Vice President of Therapeutics N/A
Ms. Julie Anne Overton Director of Communications N/A
Mr. Steven Girgenti Founder & Executive Chairman of the Board 93.33k 1946 (79 years)
Mr. Dallas J. Coleman Vice President of sales N/A

Address: United States, San Antonio. TX, 22211 West Interstate 10 - open in Google maps, open in Yandex maps
Website: https://www.bioaffinitytech.com